vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Installed Building Products, Inc. (IBP). Click either name above to swap in a different company.

Installed Building Products, Inc. is the larger business by last-quarter revenue ($747.5M vs $487.7M, roughly 1.5× CLOVER HEALTH INVESTMENTS, CORP.). Installed Building Products, Inc. runs the higher net margin — 10.2% vs -10.1%, a 20.4% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -0.4%). Installed Building Products, Inc. produced more free cash flow last quarter ($49.3M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 3.9%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Installed Building Products, Inc. is a leading US-based provider of professional installation services for building products. Core offerings include insulation, gutters, garage doors, fire protection systems and window treatments, serving residential new construction, repair & remodel, and commercial construction segments across most US regions.

CLOV vs IBP — Head-to-Head

Bigger by revenue
IBP
IBP
1.5× larger
IBP
$747.5M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+45.1% gap
CLOV
44.7%
-0.4%
IBP
Higher net margin
IBP
IBP
20.4% more per $
IBP
10.2%
-10.1%
CLOV
More free cash flow
IBP
IBP
$118.3M more FCF
IBP
$49.3M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
3.9%
IBP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
IBP
IBP
Revenue
$487.7M
$747.5M
Net Profit
$-49.3M
$76.6M
Gross Margin
35.0%
Operating Margin
-10.1%
14.6%
Net Margin
-10.1%
10.2%
Revenue YoY
44.7%
-0.4%
Net Profit YoY
-123.2%
14.5%
EPS (diluted)
$2.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
IBP
IBP
Q4 25
$487.7M
$747.5M
Q3 25
$496.6M
$778.2M
Q2 25
$477.6M
$760.3M
Q1 25
$462.3M
$684.8M
Q4 24
$337.0M
$750.2M
Q3 24
$331.0M
$760.6M
Q2 24
$356.3M
$737.6M
Q1 24
$346.9M
$692.9M
Net Profit
CLOV
CLOV
IBP
IBP
Q4 25
$-49.3M
$76.6M
Q3 25
$-24.4M
$74.4M
Q2 25
$-10.6M
$69.0M
Q1 25
$-1.3M
$45.4M
Q4 24
$-22.1M
$66.9M
Q3 24
$-9.2M
$68.6M
Q2 24
$7.4M
$65.2M
Q1 24
$-19.2M
$55.9M
Gross Margin
CLOV
CLOV
IBP
IBP
Q4 25
35.0%
Q3 25
34.0%
Q2 25
34.2%
Q1 25
32.7%
Q4 24
33.6%
Q3 24
24.5%
33.8%
Q2 24
30.3%
34.1%
Q1 24
23.6%
33.8%
Operating Margin
CLOV
CLOV
IBP
IBP
Q4 25
-10.1%
14.6%
Q3 25
-4.9%
13.7%
Q2 25
-2.2%
13.3%
Q1 25
-0.3%
10.2%
Q4 24
-6.4%
13.1%
Q3 24
-2.7%
13.3%
Q2 24
2.0%
12.9%
Q1 24
-6.5%
12.7%
Net Margin
CLOV
CLOV
IBP
IBP
Q4 25
-10.1%
10.2%
Q3 25
-4.9%
9.6%
Q2 25
-2.2%
9.1%
Q1 25
-0.3%
6.6%
Q4 24
-6.6%
8.9%
Q3 24
-2.8%
9.0%
Q2 24
2.1%
8.8%
Q1 24
-5.5%
8.1%
EPS (diluted)
CLOV
CLOV
IBP
IBP
Q4 25
$2.81
Q3 25
$2.74
Q2 25
$2.52
Q1 25
$1.64
Q4 24
$2.39
Q3 24
$2.44
Q2 24
$2.30
Q1 24
$1.97

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
IBP
IBP
Cash + ST InvestmentsLiquidity on hand
$78.3M
$321.9M
Total DebtLower is stronger
$886.6M
Stockholders' EquityBook value
$308.7M
$709.9M
Total Assets
$541.0M
$2.1B
Debt / EquityLower = less leverage
1.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
IBP
IBP
Q4 25
$78.3M
$321.9M
Q3 25
$333.3M
Q2 25
$305.2M
Q1 25
$298.7M
Q4 24
$194.5M
$327.6M
Q3 24
$288.0M
$406.2M
Q2 24
$254.8M
$380.3M
Q1 24
$208.3M
$399.9M
Total Debt
CLOV
CLOV
IBP
IBP
Q4 25
$886.6M
Q3 25
$880.8M
Q2 25
$876.1M
Q1 25
$872.4M
Q4 24
$874.8M
Q3 24
$872.3M
Q2 24
$875.8M
Q1 24
$875.0M
Stockholders' Equity
CLOV
CLOV
IBP
IBP
Q4 25
$308.7M
$709.9M
Q3 25
$340.9M
$678.6M
Q2 25
$344.2M
$664.5M
Q1 25
$336.1M
$660.9M
Q4 24
$341.1M
$705.3M
Q3 24
$342.2M
$716.4M
Q2 24
$324.9M
$685.3M
Q1 24
$292.5M
$679.2M
Total Assets
CLOV
CLOV
IBP
IBP
Q4 25
$541.0M
$2.1B
Q3 25
$559.7M
$2.1B
Q2 25
$575.0M
$2.0B
Q1 25
$583.7M
$2.0B
Q4 24
$580.7M
$2.1B
Q3 24
$653.0M
$2.1B
Q2 24
$674.2M
$2.0B
Q1 24
$671.8M
$2.0B
Debt / Equity
CLOV
CLOV
IBP
IBP
Q4 25
1.25×
Q3 25
1.30×
Q2 25
1.32×
Q1 25
1.32×
Q4 24
1.24×
Q3 24
1.22×
Q2 24
1.28×
Q1 24
1.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
IBP
IBP
Operating Cash FlowLast quarter
$-66.9M
$64.9M
Free Cash FlowOCF − Capex
$-69.0M
$49.3M
FCF MarginFCF / Revenue
-14.1%
6.6%
Capex IntensityCapex / Revenue
0.4%
2.1%
Cash ConversionOCF / Net Profit
0.85×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$300.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
IBP
IBP
Q4 25
$-66.9M
$64.9M
Q3 25
$12.1M
$124.0M
Q2 25
$5.4M
$90.4M
Q1 25
$-16.3M
$92.1M
Q4 24
$34.8M
$74.8M
Q3 24
$50.0M
$101.4M
Q2 24
$44.8M
$79.0M
Q1 24
$25.9M
$84.8M
Free Cash Flow
CLOV
CLOV
IBP
IBP
Q4 25
$-69.0M
$49.3M
Q3 25
$11.4M
$104.8M
Q2 25
$4.8M
$74.8M
Q1 25
$-16.5M
$71.9M
Q4 24
$33.3M
$52.9M
Q3 24
$49.6M
$77.3M
Q2 24
$44.4M
$58.2M
Q1 24
$25.5M
$63.0M
FCF Margin
CLOV
CLOV
IBP
IBP
Q4 25
-14.1%
6.6%
Q3 25
2.3%
13.5%
Q2 25
1.0%
9.8%
Q1 25
-3.6%
10.5%
Q4 24
9.9%
7.1%
Q3 24
15.0%
10.2%
Q2 24
12.5%
7.9%
Q1 24
7.3%
9.1%
Capex Intensity
CLOV
CLOV
IBP
IBP
Q4 25
0.4%
2.1%
Q3 25
0.1%
2.5%
Q2 25
0.1%
2.1%
Q1 25
0.0%
2.9%
Q4 24
0.5%
2.9%
Q3 24
0.1%
3.2%
Q2 24
0.1%
2.8%
Q1 24
0.1%
3.1%
Cash Conversion
CLOV
CLOV
IBP
IBP
Q4 25
0.85×
Q3 25
1.67×
Q2 25
1.31×
Q1 25
2.03×
Q4 24
1.12×
Q3 24
1.48×
Q2 24
6.04×
1.21×
Q1 24
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

IBP
IBP

Residential New Construction$488.6M65%
Other Customer Installation$67.8M9%
Shower Doors Shelving And Mirrors$53.5M7%
Other Building Products$47.7M6%
Fireproofing And Firestopping$37.6M5%
Rain Gutters$31.3M4%
Window Blinds$18.0M2%
Related Party$6.7M1%

Related Comparisons